Testican-2: from glomerular activity to circulating biomarker

Testican-2, encoded by SPOCK2 , is a secreted extracellular matrix-associated proteoglycan involved in podocyte and glomerular biology. The kidney contributes to the circulating Testican-2 pool, with podocytes representing a major renal source. Higher circulating levels are generally associated with better-preserved kidney function, less proteinuria, more favorable renal outcomes, and milder glomerular pathology, although these relationships vary across disease settings. In vitro and rodent studies show that Testican-2 binds vitronectin, restrains excessive integrin αVβ3 activation, and attenuates podocyte and filtration barrier injury. However, plasma abundance cannot yet be assumed to reflect the biologically active glomerular pool, because circulating levels may also be influenced by extracellular retention, glycosylation, proteolytic processing, and clearance. This uncertainty limits both biomarker interpretation and therapeutic translation. This Mini Review integrates clinical and experimental evidence to clarify what circulating Testican-2 may represent and identify the studies needed to connect plasma measurements with local glomerular activity.

Authors

Institutions

Publication Details

Journal
Frontiers in Physiology
Published
2026-10-26
DOI
https://doi.org/10.3389/fphys.2026.1953293
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Testican-2: from glomerular activity to circulating biomarker

Liyan Jiang, Jiao Luo, Xin-Hua Xiao, Heng Sun
Frontiers in Physiology
Renal Diseases and Glomerulopathies
article

Testican-2: from glomerular activity to circulating biomarker

Liyan Jiang, Jiao Luo, Xin-Hua Xiao, Heng Sun
article en

Abstract

Testican-2, encoded by SPOCK2 , is a secreted extracellular matrix-associated proteoglycan involved in podocyte and glomerular biology. The kidney contributes to the circulating Testican-2 pool, with podocytes representing a major renal source. Higher circulating levels are generally associated with better-preserved kidney function, less proteinuria, more favorable renal outcomes, and milder glomerular pathology, although these relationships vary across disease settings. In vitro and rodent studies show that Testican-2 binds vitronectin, restrains excessive integrin αVβ3 activation, and attenuates podocyte and filtration barrier injury. However, plasma abundance cannot yet be assumed to reflect the biologically active glomerular pool, because circulating levels may also be influenced by extracellular retention, glycosylation, proteolytic processing, and clearance. This uncertainty limits both biomarker interpretation and therapeutic translation. This Mini Review integrates clinical and experimental evidence to clarify what circulating Testican-2 may represent and identify the studies needed to connect plasma measurements with local glomerular activity.

Frontiers in PhysiologyVol. 17
First Affiliated Hospital of University of South China (CN), University of South China (CN)
Openalex Percentile: Top 12%
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon